Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4348 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Brain Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Brain Cancer Peripheral Blood Mononuclear Cells are mainly derived from the patient’s peripheral blood. They are represent a heterogeneous cell population, including lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are round or oval. PBMCs are mainly involved in immune surveillance and tumor microenvironment regulation in brain cancer: CD8+ T cells can recognize tumor antigens, NK cells mediate natural killing, and monocytes differentiate into tumor-associated macrophages (TAMs), which may have both tumor-promoting and tumor-suppressive functions.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Brain Cancer Peripheral Blood Mononuclear Cells can be used for immunotherapy research, such as in vitro expansion and functional evaluation of CAR-T cell therapy, or target screening to enhance anti-tumor immune responses. In addition, immunophenotyping of PBMCs (such as PD-1 and CTLA-4 expression levels) can assess the patient’s immunosuppressive status and guide immune checkpoint inhibitor therapy.